RICE HALL JAMES & ASSOCIATES LLC
Q2 2026 Form 13-F

SAN DIEGO, CALIFORNIA
CIK 0001230765 · CRD 125410 · SEC-registered investment adviser
$2.1B Reported Value Total

RICE HALL JAMES & ASSOCIATES LLC reports 249 total accounts under management (AUM). There are 249 discretionary accounts valued at $1,740,251,833, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Firm Brochure (Part 2A)
Private funds (Form ADV)
1 fund · $15.9M gross asset value
Hedge Fund: $15.9M
Source: Form ADV filed 2026-05-06
Reported value
$2.1B
Quarter over quarter
+14.9%
Holdings
240
Top-10 concentration
24.1%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Thuong-Thao Nguyen Buu-Hoan
MANAGING MEMBER, CHIEF OPERATING OFFICER, PRESIDENT
Louis Millett Holtz
MANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER
Yossef Ytzhak Lipsker
MANAGING MEMBER, PORTFOLIO MANAGER
Q1 2026

Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.

Loading 13F Metrics

Q2 2026 13F filing summary

Period of report June 30, 2026
Filed August 07, 2026
Form 13F-HR
Reported value $2.1B
Positions 240
Change in reported value +14.4%
New positions 14
Exited positions 17
Position turnover 12.1%
Top-10 concentration 24.1%

13F filings by quarter

Quarter Positions Value
Q2 2026 13F
Filed Aug 7, 2026
 240 $2.1B
Q1 2026 13F
Filed May 15, 2026
 243 $1.8B
Q4 2025 13F
Filed Feb 17, 2026
 243 $1.8B
Q3 2025 13F
Filed Oct 16, 2025
 248 $1.8B
Q2 2025 13F
Filed Aug 11, 2025
 247 $1.9B
Q1 2025 13F
Filed May 1, 2025
 248 $1.7B
Q4 2024 13F
Filed Jan 31, 2025
 249 $1.8B
Q3 2024 13F
Filed Oct 28, 2024
 250 $1.8B
Q2 2024 13F
Filed Aug 7, 2024
 256 $1.7B
Q1 2024 13F
Filed Apr 23, 2024
 257 $1.8B
Q4 2023 13F
Filed Feb 9, 2024
 260 $1.7B
Q3 2023 13F
Filed Nov 2, 2023
 260 $1.6B
Q2 2023 13F
Filed Jul 24, 2023
 262 $1.8B
Q1 2023 13F
Filed May 12, 2023
 262 $1.8B
Q4 2022 13F
Filed Jan 27, 2023
 260 $1.7B
Q3 2022 13F
Filed Nov 1, 2022
 265 $1.7B
Q2 2022 13F
Filed Aug 8, 2022
 265 $2.1B
Q1 2022 13F
Filed May 5, 2022
 306 $2.5B
Q4 2021 13F
Filed Feb 14, 2022
 312 $2.8B
Q3 2021 13F
Filed Nov 9, 2021
 309 $2.7B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2026

# Holding Reported value % of portfolio
1 LGND LIGAND PHARMACEUTICALS INC $85.4M 4.15%
2 ACIW ACI WORLDWIDE INC $50.6M 2.46%
3 ARLO ARLO TECHNOLOGIES INC $50.3M 2.45%
4 FN FABRINET $49.2M 2.4%
5 ESTA ESTABLISHMENT LABS HLDGS INC $48.1M 2.34%
6 XPO XPO INC $46.2M 2.25%
7 ZD ZIFF DAVIS INC $43.0M 2.09%
8 FOUR SHIFT4 PMTS INC $42.5M 2.07%
9 KNSA KINIKSA PHARMACEUTICALS INTL $40.0M 1.95%
10 ASND ASCENDIS PHARMA A/S $39.6M 1.93%
11 LRN STRIDE INC $37.9M 1.84%
12 PBH PRESTIGE CONSMR HEALTHCARE I $32.6M 1.59%
13 DFIN DONNELLEY FINL SOLUTIONS INC $32.5M 1.58%
14 ITRN ITURAN LOCATION AND CONTROL $29.0M 1.41%
15 MEDP MEDPACE HLDGS INC $28.7M 1.39%
16 AWI ARMSTRONG WORLD INDS INC NEW $28.4M 1.38%
17 GDDY GODADDY INC $28.1M 1.37%
18 BIRK BIRKENSTOCK HOLDING PLC $27.1M 1.32%
19 YOU CLEAR SECURE INC $27.0M 1.32%
20 NGVT INGEVITY CORP $26.2M 1.28%

Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.

Loading Activities
Loading Sector Allocation
Crunching numbers
Loading Performance
Finding Similar Managers
Finding Potential New Buys
Building table
Loading SEC filing data
Loading Form 4 Filings
Loading 13D/G filings